Asian Fund for Cancer Research Limited (AFCR) is a legal charity registered in Hong Kong and has obtained tax exemption status from the Inland Revenue Department (IRD). Our address is:
For other inquiries:
Asian Fund for Cancer Research Limited
5/F Dah Sing Life Building,
99-105 Des Voeux Road Central, Hong Kong
Tel: (852) 2156 9684
Fax: (852) 2156 9685
AFCR believes that the best way to combat cancer is through a two-pronged approach which combines the power of cancer research and prevention education. AFCR is dedicated to bridging the scientific and educational gaps in both areas between Asian countries and the rest of the world through promoting, coordinating and funding international collaboration in cancer research and public education. AFCR, therefore, is dually focused on the need to both enhance the general public’s awareness of how to protect themselves, and at the same time, to proactively translate discoveries made in the laboratory and quickly bring them to the bedsides of patients.
1. Cutting-edge research in common cancers in Asia:
AFCR provides research and development funding to support the most innovative ideas relating to cancer prevention, early diagnosis and treatment. The AFCR funding is specifically focused on cancers that have significant impacts on Asian populations, which include lung, esophageal, colorectal and ovarian cancers. This includes projects that investigate novel approaches to overcoming resistance to chemotherapy, developing screening tests for early detection, optimizing the methods of practicing personalized medicine, and validating biomarkers for risk prediction of cancer metastasis or recurrence.
2. Synergistic collaborations across scientific disciplines:
Important breakthroughs in cancer research often come out of synergistic collaborations among scientists. As a result, besides providing flexible funding for individual innovative cancer research projects, AFCR is working to establish a number of collaboration platforms for our researchers. By fostering frequent interactions among our outstanding scientists, resources can be most effectively leveraged, and discoveries can be more quickly translated into new clinical practices that benefit cancer patients.
3. Science-based cancer awareness and prevention education:
Knowing the importance of a balanced diet and the benefits of regular exercise is just as critical as understanding the true nature of cancer.
AFCR’s public education series provides in-depth, user-friendly informational brochures and documents that not only provide new updates on the most recent breakthroughs in cancer research but also offer science-based education and advice to people on how to improve their diet and lifestyle, both of which will lead to longer and healthier lives.
The AFCR Peer Review Committee is composed of leading cancer researchers from research institutions in Asia and the United States. The review process takes into account multiple factors of the received applications: the significance of the proposed research and impact on basic, translational and/or clinical research; the soundness of the scientific approach; the practicality and achievability of the short- and long-term objectives; novelty of the project; experience and productivity of the investigator(s); the facilities and resources available at their affiliated institutions; and the progresses during past funding cycle (renewal applications.) Due to the limited resources available to AFCR, our Scientific Review Committee ranks the proposals and provides funds only to those who meet the highest standards.
• HK$40-$50 – Buys one bottle of culture medium to grow cancer cells in the lab for research use
• HK$240 – Collects and stores one valuable tumor tissue at the Tissue Bank for molecular and genetic analysis
• HK$200-$800 – Stains one tissue slide from a tumor biopsy to look for a predictive biomarker of cancer metastasis
• HK$800 – Evaluates one tumor biomarker for one patient to help him/her to receive the most beneficial therapy available
• HK$2,000 – Buys one case of Petri dishes to grow cancer cells on a larger scale
• HK$4,000-$6,000 – Buys one antibody for testing whether tumor cells have a marker for drug resistance